GlassScriptPhysician profile
Raymond D Pastore
NPI 1124027487
$15,863.45
in general payments reported to CMS, 2019-2025
20 companies · $356 in 2025
The $356 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,690 · 2020: $5,354 · 2021: $215 · 2022: $108 · 2023: $55.20 · 2024: $85.97 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481 · Education: $16.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $480.59 |
| Education | $16.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rigel Pharmaceuticals, INC. | $7,155.83 | 2019-2021 | |
| Bioverativ Therapeutics INC. | $4,420.50 | 2019-2020 | |
| Dova Pharmaceuticals | $1,404.72 | 2019-2020 | |
| Amgen INC. | $1,339.46 | 2019 | |
| Genzyme Corporation | $275.54 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $198.32 | 2019-2025 | |
| Celgene Corporation | $158.55 | 2019-2025 | Reblozyl |
| Agios Pharmaceuticals, INC. | $157.28 | 2024-2025 | Pyrukynd |
| Janssen Pharmaceuticals, INC | $125.00 | 2019 | |
| Daiichi Sankyo INC. | $116.61 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $107.86 | 2022 | |
| Incyte Corporation | $75.40 | 2019 | |
| Sobi, INC | $69.44 | 2024 | |
| Alexion Pharmaceuticals, INC. | $68.51 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $48.62 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $42.08 | 2019 | |
| Janssen Biotech, INC. | $34.65 | 2019 | |
| Shire North American Group INC | $24.56 | 2019 | |
| Octapharma USA, INC. | $22.19 | 2019 | |
| Emmaus Medical, INC. | $18.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Pastore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.